Factor B Activators
The class of chemicals known as Factor B activators comprises a diverse range of compounds that intricately modulate cellular pathways to influence the activation of Factor B. These chemicals exploit various cellular mechanisms, with a primary focus on the NF-κB signaling pathway. Nordihydroguaiaretic acid (NDGA), for instance, disrupts arachidonic acid metabolism, indirectly enhancing NF-κB signaling. This enhanced signaling, in turn, leads to the activation of Factor B. The intricate nature of NDGA's influence showcases the complexity of cellular pathways involved in Factor B activation. Resveratrol, another notable chemical in this class, modulates the activity of SIRT1. This modulation facilitates NF-κB transcriptional activity, ultimately resulting in the activation of Factor B. The involvement of Resveratrol in the NF-κB pathway highlights the multifaceted mechanisms through which chemicals in this class operate to regulate Factor B.
A769662, identified as an AMP-activated protein kinase (AMPK) activator, indirectly activates Factor B by inhibiting mTORC1. mTORC1 is a negative regulator of NF-κB, and its inhibition by A769662 creates a conducive environment for NF-κB signaling, leading to Factor B activation. Bay 11-7082, a potent IκB phosphorylation inhibitor, plays a role in maintaining NF-κB in an inactive state. This maintenance indirectly contributes to Factor B activation by regulating the NF-κB signaling pathway. Troglitazone, classified as a PPAR-γ agonist, exerts its influence by suppressing NF-κB activity. This suppression creates a favorable cellular environment for Factor B activation. Collectively, these chemicals exemplify the intricate interplay of cellular pathways involved in the modulation of Factor B activity. The diverse mechanisms showcased by NDGA, Resveratrol, A769662, Bay 11-7082, and Troglitazone underscore the complexity of the regulatory networks that govern Factor B activation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NDGA (Nordihydroguaiaretic acid) | 500-38-9 | sc-200487 sc-200487A sc-200487B | 1 g 5 g 25 g | $109.00 $384.00 $2190.00 | 3 | |
NDGA inhibits lipoxygenase and cyclooxygenase pathways, affecting arachidonic acid metabolism. This disruption in eicosanoid synthesis indirectly activates Factor B through enhanced NF-κB signaling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol modulates SIRT1 activity, leading to deacetylation of RelA/p65 subunit of NF-κB. This modification facilitates nuclear translocation, enhancing the transcriptional activity of NF-κB and subsequently activating Factor B. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 is an AMP-activated protein kinase (AMPK) activator. AMPK activation inhibits mTORC1, a negative regulator of NF-κB. This indirect modulation results in heightened NF-κB signaling and subsequent activation of Factor B. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082 is an inhibitor of IκB phosphorylation, preventing its degradation and maintaining NF-κB in an inactive state. Disruption of this regulatory mechanism leads to increased NF-κB signaling, indirectly activating Factor B. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
Troglitazone is a PPAR-γ agonist that suppresses NF-κB activity. The decreased competition for co-activators between NF-κB and Factor B promotes Factor B activation. | ||||||
BAY 61-3606 | sc-507485 | 2 mg | $345.00 | 1 | ||
BAY 61-3606 is a Syk kinase inhibitor. Its impact on the B-cell receptor (BCR) signaling pathway indirectly affects NF-κB, contributing to the activation of Factor B. | ||||||
Caffeic acid phenethyl ester | 104594-70-9 | sc-200800 sc-200800A sc-200800B | 20 mg 100 mg 1 g | $71.00 $296.00 $612.00 | 19 | |
Caffeic acid phenethyl ester inhibits IKKβ, a key regulator of NF-κB activation. Inhibition of IKKβ prevents IκB phosphorylation and degradation, enhancing NF-κB signaling and subsequently activating Factor B. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol inhibits Hsp90, leading to the degradation of client proteins, including IKKβ. The disruption in NF-κB signaling indirectly activates Factor B through enhanced nuclear translocation of NF-κB. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol is a cyclin-dependent kinase (CDK) inhibitor. CDKs regulate NF-κB activity, and inhibition by flavopiridol disrupts this control, indirectly activating Factor B through the upregulation of NF-κB signaling. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $214.00 $257.00 $1775.00 $2003.00 | 34 | |
This compound, also called JSH-23, inhibits the nuclear translocation of NF-κB by blocking its interaction with importin α. The resultant increase in cytoplasmic NF-κB indirectly activates Factor B through the prolonged retention of NF-κB in the cytoplasm. | ||||||